Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A2 | P23975 | 1/20 | 0.41 |
| ▸ | LGALS8 | O00214 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.37 |
| ▸ | RPS6KA3 | P51812 | 1/20 | 0.37 |
| ▸ | RPS6KA1 | Q15418 | 1/20 | 0.37 |
| ▸ | FGF1 | P05230 | 2/20 | 0.36 |
| ▸ | FGF2 | P09038 | 2/20 | 0.36 |
| ▸ | VEGFA | P15692 | 2/20 | 0.36 |
| ▸ | HPSE | Q9Y251 | 2/20 | 0.36 |
| ▸ | LMNA | P02545 | 2/20 | 0.36 |
| ▸ | GJB2 | P29033 | 1/20 | 0.36 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.36 |
| ▸ | MTOR | P42345 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13129990 | 1.00 | SLC6A2 (0.41) | SLC6A2LGALS8ALDH1A1CYP2D6CYP3A4 | |
| SCHEMBL15975400 | 1.00 | SLC6A2 (0.41) | SLC6A2LGALS8ALDH1A1CYP2D6CYP3A4 | |
| SCHEMBL13129886 | 0.91 | ALDH1A1 (0.40) | ALDH1A1CYP2D6CYP3A4FGF1FGF2 | |
| SCHEMBL13129884 | 0.91 | ALDH1A1 (0.40) | ALDH1A1CYP2D6CYP3A4FGF1FGF2 | |
| SCHEMBL13129845 | 0.91 | ALDH1A1 (0.40) | ALDH1A1CYP2D6CYP3A4FGF1FGF2 | |
| SCHEMBL13129844 | 0.91 | ALDH1A1 (0.40) | ALDH1A1CYP2D6CYP3A4FGF1FGF2 | |
| SCHEMBL13129843 | 0.90 | ALDH1A1 (0.38) | ALDH1A1CYP2D6FGF1FGF2VEGFA | |
| SCHEMBL13129893 | 0.90 | ALDH1A1 (0.38) | ALDH1A1CYP2D6FGF1FGF2VEGFA | |
| SCHEMBL13130043 | 0.90 | ALDH1A1 (0.38) | ALDH1A1CYP2D6FGF1FGF2VEGFA | |
| SCHEMBL13130005 | 0.90 | ALDH1A1 (0.38) | ALDH1A1CYP2D6FGF1FGF2VEGFA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8815239-B2 | Glycoconjugates and use thereof as vaccine against Shigella flexneri serotype 3a and X | INSTITUT PASTEUR (FR) | 2014-08-26 | — | — | US | disclosed |
| US-20100239584-A1 | GLYCOCONJUGATES AND USE THEREOF AS VACCINE AGAINST SHIGELLA FLEXNERI SEROTYPE 3A AND X | INSTITUT PASTEUR (FR) | 2010-09-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100239584-A1 | GLYCOCONJUGATES AND USE THEREOF AS VACCINE AGAINST SHIGELLA FLEXNERI SEROTYPE 3A AND X | ST3GAL3, SI, STT3A | SLC6A2 2998/4885LGALS8 130/4885ALDH1A1 3090/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.